CGIM
MNOV icon

Cannon Global Investment Management’s MediciNova MNOV Stock Holding History

Cannon Global Investment Management’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,000
Closed -$85K – 63
2021
Q2 		$85K Buy
+20,000
New +$86.2K 0.17% 41

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cannon Global Investment Management's MNOV Position: Q3 2021 in Review

Cannon Global Investment Management sold out of MediciNova (MNOV) in Q3 2021, closing a stake of 20,000 shares — an estimated $85K sold.

Cannon Global Investment Management first reported a position in MNOV in Q2 2021 and held it in 1 quarter. The position peaked at $85K in Q2 2021. 39 funds tracked by Wall St. Rank hold MNOV as of Q3 2021.

  • Cannon Global Investment Management reported no remaining MediciNova position as of Q3 2021 after selling out during the quarter.
  • Cannon Global Investment Management sold 20,000 MediciNova shares in Q3 2021, an estimated $85K.
  • Cannon Global Investment Management first reported a position in MediciNova in Q2 2021 and held it in 1 quarter.
  • Cannon Global Investment Management's MediciNova position peaked at $85K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held MediciNova as of Q3 2021.

Based on Cannon Global Investment Management's 13F filing for Q3 2021, filed 27 Oct 2021.